IU Institute of Oncology Assoc. Prof. Dr.Semra Demokan is considered worthy to the prize of the best poster presentation with her study titled as “Investigation of the methylation status of COX2(Cyclooxygenase 2) gene pro moter region in larynx Cancer” in “7th European Congress on Head and Neck Oncology” which is held in Hungary Budapest between 7-10 September 2016.
In the study, the possible biomarker potential of the methylation status of Cyclooxygenase 2 gene, which has a part in Prostaglandin biosynthesis, pro moter region in larynx cancer has been investigated. The study contributes the diagnosis of larynx cancer. The other researhers in the study: IU Oncology Institute Retired Prof. Dr. Nejat Dalay, IU Faculty of Medicine Specialist Murat Ulusan, IU Oncology Institute Graduate Student Sevde Cömert and Specialist Necati Enver.
Translated by: İrem YAŞAR
IU Press and Public Relationship Department